Log in
Sign Up. It's Free
Last Update: Oct, 21 2024
Overview
Dosage & Administration
Drug label
PubMed™ News
FAQ
Zelboraf
(vemurafenib)
Zelboraf 240 MG Oral Tablet
NO BOXED WARNING
Dosage & Administration
* Confirm the presence of BRAF V600E mutation in tumor specimens prior to initiation of treatment with ZELBORAF.
* Recommended dose: 960 mg orally twice daily taken approximately 12 hours apart with or without a meal.
Zelboraf Prescribing Information
Report Adverse Event
Zelboraf PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Zelboraf FAQs
How is the dosage of Zelboraf?
Zelboraf is available in 1 dosages, including 240 mg Tab
What does Zelboraf treat?
Zelboraf treats Melanoma
What is Zelboraf made of?
Zelboraf contains vemurafenib which is a Kinase Inhibitor
How Is Zelboraf Administered?
Zelboraf is administered as a Oral Pill
What Are The Zelboraf Mechanism Of Action?
Zelboraf mechanism of action is Protein Kinase Inhibitors, Cytochrome P450 1A2 Inhibitors or P-Glycoprotein Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
